C. Ravaglia (Forlì, Italy), E. Bargagli (Siena, Italy)
Comparative analysis of the efficacy of glucocorticosteroids and antimetabolite drugs in treatment of patients with pulmonary sarcoidosis
I. Merenkova (Kyiv, Ukraine), Y. Dziublyk (Kyiv, Ukraine), G. Gumeniuk (Kyiv, Ukraine)
|   |
The role of salivary gland biopsy in the diagnosis of sarcoidosis
G. Okumus (Istanbul, Turkey), Z. Bingol (Istanbul, Turkey), M. Sarisoy (Istanbul, Turkey), T. Cagatay (Istanbul, Turkey), E. Kiyan (Istanbul, Turkey), Z. Kilicaslan (Istanbul, Turkey)
| |
The utility of transthoracic lung ultrasound in assessing pulmonary sarcoidosis
M. Piprek (Gdansk, Poland), M. Kryger (Gdansk, Poland), W. Kosiak (Gdansk, Poland), M. Dubaniewicz-Wybieralska (Gdansk, Poland), M. Skotarczak (Gdansk, Poland), J. Slominski (Gdansk, Poland), A. Dubaniewicz (Gdansk, Poland)
| |
Relationship between sarcoidosis health outcome and lower socioeconomic status in Tunisian patients
A. Ben mansour (Tunis, Tunisia), H. Daghfous (Tunis, Tunisia), A. Slim (Tunis, Tunisia), S. Ben Saad (Tunis, Tunisia), L. Fekih (Tunis, Tunisia), M. Megdiche (Tunis, Tunisia), F. Tritar (Tunis, Tunisia)
| |
Epidemiology of sarcoidosis in Western Ukraine
M. Ostrovskyy (Ivano-Frankivsk, Ukraine), K. Ostrovska (Ivano-Frankivsk, Ukraine), K. Shvets (Ivano-Frankivsk, Ukraine), I. Savelikhina (Ivano-Frankivsk, Ukraine), O. Varunkiv (Ivano-Frankivsk, Ukraine), N. Korzh (Ivano-Frankivsk, Ukraine)
| |
The role of obesity in patients with sarcoidosis
V. Sholomova (Moscow, Russian Federation), M. Brovko (Moscow, Russian Federation), L. Akulkina (Moscow, Russian Federation), L. Lysenko (Moscow, Russian Federation), S. Moiseev (Moscow, Russian Federation), L. Samokhodskaya (Moscow, Russian Federation), T. Krasnova (Moscow, Russian Federation)
| |
Prevalence of Depression in Sarcoidosis: a comparison with asthmatic and healthy controls
N. Bernardinello (Parma, Italy), V. Alfieri (Parma, Italy), C. Turatto (Parma, Italy), P. Ossola (Parma, Italy), E. Illica Magrini (Parma, Italy), M. Aiello (Parma, Italy), E. Crisafulli (Parma, Italy), A. Chetta (Parma, Italy), G. Bertorelli (Parma, Italy)
| |
Clinical manifestation of small fiber neuropathy in patients with sarcoidosis and tuberculosis
N. Basantsova (Saint Petersburg, Russian Federation), Y. Zinchenko (Saint Petersburg, Russian Federation), V. Shapkina (Saint Petersburg, Russian Federation), A. Dori (Tel Aviv, Israel), A. Starshinova (Saint Petersburg, Russian Federation), P. Yablonskiy (Saint Petersburg, Russian Federation)
| |
Algorithm for pulmonary hypertension screening in sarcoidosis: A Delphi Consensus
L. Savale (Le Kremlin Bicêtre, France), M. Humbert (Le Kremlin Bicêtre, France), A. Wells (London, United Kingdom), S. Nathan (Falls Church, United States of America), R. Gupta (Philadelphia, United States of America), M. Huitema (Nieuwegein, Netherlands), X. Jais (Le Kremlin Bicêtre, France), J. Grutters (Nieuwegein, Netherlands), V. Kouranos (London, United Kingdom), D. Montani (Le Kremlin Bicêtre, France), O. Shlobin (Falls Church, United States of America), O. Sitbon (Le Kremlin Bicêtre, France), R. Baughman (Cincinnati, United States of America)
| |
GRANULOMATOUS-LYMPHOCYTIC INTERSTITIAL LUNG DISEASE (GLILD) IN CVID: A CASE-CONTROL SINGLE CENTER RETROSPECTIVE STUDY
F. Cinetto (Treviso, Italy), R. Scarpa (Treviso, Italy), R. Neri (Treviso, Italy), S. Gianese (Treviso, Italy), C. Agostini (Treviso, Italy)
| |
Fc?RIIA, Fc?RIII and Fc?RIIB expression in sarcoid granuloma and foreign body granuloma of the skin.
A. Dubaniewicz (Gdansk, Poland), B. Rekawiecki (Gdansk, Poland), A. Zawrocki (Gdansk, Poland), H. Majewska (Gdansk, Poland), M. Piprek (Gdansk, Poland), W. Biernat (Gdansk, Poland)
| |
Immunophenotyping of CD34 + cells in peripheral blood of patients with lung sarcoidosis
E. Rutkowska (Warsaw, Poland), I. Kwiecien (Warsaw, Poland), A. Szamalek (Warsaw, Poland), J. Zarzycka (Warsaw, Poland), K. Jahnz-Rózyk (Warsaw, Poland), P. Rzepecki (Warsaw, Poland)
| |
Treatment of sarcoidosis – pentoxifylline
D. Semotiuk (Lviv, Ukraine), O. Tolokh (Lviv, Ukraine), N. Rudnitska (Lviv, Ukraine)
| |
Biomarkers of Sarcoidosis: a comparative study of serum chitotriosidase, ACE, lysozyme and KL-6
P. Cameli (Siena, Italy), L. Bergantini (Siena, Italy), F. Bianchi (Siena, Italy), M. Mazzei (Siena, Italy), P. Sestini (Siena, Italy), P. Rottoli (Siena, Italy), E. Bargagli (Siena, Italy)
| |
Longitudinal micro-CT-derived biomarkers: the new standard readouts for preclinical evaluation of pulmonary fibrosis and therapy
K. Dekoster (Leuven, Belgium), T. Decaesteker (Leuven, Belgium), N. Berghen (Leuven, Belgium), A. Jonckheere (Leuven, Belgium), J. Wouters (Leuven, Belgium), R. Lories (Leuven, Belgium), P. Hoet (Leuven, Belgium), J. Vanoirbeek (Leuven, Belgium), G. Vande Velde (Leuven, Belgium)
| |
Genetic polymorphisms of the renin-angiotensin system: role in patients with sarcoidosis
V. Sholomova (Moscow, Russian Federation), M. Brovko (Moscow, Russian Federation), L. Akulkina (Moscow, Russian Federation), L. Francusevica (Moscow, Russian Federation), M. Lebedeva (Moscow, Russian Federation), L. Samokhodskaya (Moscow, Russian Federation), T. Krasnova (Moscow, Russian Federation)
| |
Genetic polymorphisms of inflammatory cytokines and endothelial dysfunction factors: role in patients with sarcoidosis
V. Sholomova (Moscow, Russian Federation), M. Brovko (Moscow, Russian Federation), L. Akulkina (Moscow, Russian Federation), L. Strizhakov (Moscow, Russian Federation), D. Konovalov (Moscow, Russian Federation), L. Samokhodskaya (Moscow, Russian Federation), T. Krasnova (Moscow, Russian Federation)
| |